yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35678690-97791356-2863-46EB-AA21-77ABDC2CB868
Q35678690-97791356-2863-46EB-AA21-77ABDC2CB868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35678690-97791356-2863-46EB-AA21-77ABDC2CB868
A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer.
P2860
Q35678690-97791356-2863-46EB-AA21-77ABDC2CB868
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35678690-97791356-2863-46EB-AA21-77ABDC2CB868
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb9c9e46e2c78d956d2e34672df90a48a5b550c8
P2860
Eribulin mesylate in patients with refractory cancers: a Phase I study.